After nearly a century of evidence insinuating that there is a correlation between Type II Diabetes (T2D) and gastrointestinal (GI) surgery, the Second Diabetes Surgery Summit (DSS-II) released a report, which confirms that bariatric surgery can diminish or entirely resolve T2D. The study of this topic began in the 1920’s, when doctors noted the resolution of diabetes after gastrointestinal operations intended to treat ulcers and cancers. This trend continued in the 1950’s with many doctors remarking on the remission of diabetes after GI surgery. In the 2000’s, research focused intentionally on discovering exactly how surgery could influence T2D, making it clear that metabolic surgery can be used as an intentional treatment of T2D. The DSS-II committee consisted of 48 physicians from seven different specialities (60% of which came from an endochrinology or diabetology background). These physicians confirmed that in addition to allowing a patient more glycemic control, metabolic surgery can allow for:
Academic jargon aside, this discovery is outstanding. Though many bariatric patients have found their T2D in remission after GI and bariatric surgery, the DSS-II has finally confirmed that this is not a coincidence—there is concrete medical evidence to explain this phenomenon. Here at Colorado Bariatric Surgery Institute, we have found that when patients are contemplating bariatric surgery, the resolution of their comorbidities is one of the major reasons they consider surgery. Contrary to popular understanding, bariatric surgery is not just about weight loss. The improvements in overall health and the resolution of a number of comorbidities—T2D among them—are the real reasons to pursue metabolic surgery.
These findings do not suggest that all people with T2D should opt for surgery to resolve this particular comorbidity, but rather that those who find themselves suffering from T2D and obesity should talk to their doctor about their options. Up to 60% of patients suffering from T2D who opt for bariatric surgery, achieve a durable normalization of blood surgery for greater than five years.
If you suffer from T2D and are looking for options to achieve remission, bring a copy of the DSS-II report to your primary care physician to discuss whether metabolic surgery might be a fit for you. If you would like to read more about surgery as a treatment for T2D, take a look at these articles, which discuss their findings on the functionality of bariatric surgery to reduce comorbidities: